Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)
Clinical trial NCT04982445 · COMPLETED
Trial details
- NCT number
- NCT04982445
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2024-01-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.